Patient | Rest1 | Conv | Rest2 | Video | Rest3 | Spearman correlation | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
bl/m; tt/m | bl/m; tt/m | bl/m; tt/m | bl/m; tt/m | bl/m; tt/m | (n=120) | ||||||||||||
1† | 38.0; 8.8 | 36.8; 1.5 | 28.0; 5.3 | 29.5; 1.8 | 30.0; 3.5 | 0.15 | |||||||||||
2 | 41.3; 0.5 | 77.3; 0.5 | 40.3; 0.0 | 58.5; 0.0 | 67.0; 0.8 | 0.10 | |||||||||||
3† | 34.5; 12.3 | 42.8; 3.5 | 32.8; 3.8 | 47.8; 15.3 | 34.0; 9.0 | −0.182-150 | |||||||||||
4† | 20.3; 1.8 | 11.3; 0.3 | 14.5; 0.8 | 19.8; 2.5 | 11.3; 0.0 | 0.312-165 | |||||||||||
5‡ | 32.5; 1.3 | 31.5; 0.0 | 31.3; 2.0 | 40.5; 5.3 | 24.3; 2.3 | 0.312-165 | |||||||||||
6† | 40.5; 7.8 | 37.8; 2.0 | 46.8; 6.0 | 44.0; 9.8 | 29.5; 3.0 | 0.282-160 | |||||||||||
7 | 37.3; 8.0 | 39.3; 8.0 | 32.0; 9.0 | 43.8; 24.3 | 40.5; 15.8 | 0.432-165 | |||||||||||
8† | 26.3; 2.3 | 80.8; 3.0 | 41.3; 5.3 | 55.0; 6.8 | 39.8; 8.8 | −0.02 | |||||||||||
9 | 21.3; 0.0 | 8.3; 0.0 | 28.8; 0.0 | 33.3; 6.0 | 36.5; 0.5 | 0.232-160 | |||||||||||
Mean | 32.4; 4.8 | 40.7; 2.12-150 | 32.9; 3.6 | 41.42-150; 8.02-150 | 34.8; 4.92-150 | ||||||||||||
(SD) | (8); (5) | (25); (3) | (9); (3) | (12); (8) | (15); (5) |
Conv=conversation; bl/m=mean number of blinks/min; tt/m=mean total number of eye tics/min. †Patients treated with neuroleptics.‡Patient treated with antidepressant. Per patient, Spearman rank correlation coefficients between the number of blinks and eye tics/10 s were computed for the whole recording (last column). Wilcoxon tests: within group change v preceding period:2-150p⩽0.05; Spearman rank correlation coefficients:
↵2-150 p<0.05;
↵2-160 p<0.01;
↵2-165 p<0.001.